NMN and DNA Repair: Sustaining Genomic Integrity

Genomic instability is a hallmark of aging. Every day, our DNA is subjected to thousands of damaging events, from UV radiation to metabolic byproducts. To survive, the body employs a sophisticated repair kit, and at the heart of this kit is a molecule called NAD+ (Nicotinamide Adenine Dinucleotide).

The NAD+ Decline

As we age, our levels of NAD+ naturally decline, often dropping by as much as 50% every 20 years. This decline cripples the cell's ability to repair itself. NMN (Nicotinamide Mononucleotide) has emerged as a primary precursor used to restore these NAD+ levels, effectively "fueling" the repair machinery.

Activating the PARPs

One of the most important consumers of NAD+ in the cell is a family of enzymes called PARPs (Poly ADP-Ribose Polymerases). When DNA is damaged, PARP1 detects the break and uses NAD+ to create a chemical signal that recruits other repair proteins to the site. Without sufficient NAD+, PARPs cannot function efficiently, and DNA damage begins to accumulate, leading to mutations and cellular senescence.

Sirtuins and Epigenetic Health

Beyond direct DNA repair, NMN-derived NAD+ activates sirtuins, a family of "longevity genes." Sirtuins are responsible for maintaining epigenetic "silence"—ensuring that genes are only expressed when they should be. By keeping the epigenome organized, sirtuins prevent the cellular "confusion" that often leads to age-related diseases.

Current Research and Human Trials

While early studies in mice showed remarkable reversals in vascular aging and muscle health, human trials are now beginning to confirm that NMN supplementation safely increases NAD+ levels in the blood. The focus is now shifting toward long-term studies to see if this biochemical boost translates into a tangible increase in human "healthspan"—the period of life spent in good health.